Cerebral palsy due to delay in the operating room?
An Illinois woman presented to a hospital in labor in late 1999 at 2 days past her due date. She had received prenatal care from her family physician. She was given oxytocin and about 9 hours later an arrest of descent was noted with some decelerations and decreased variability of the FHR. An obstetrician mentioned possible cesarean section at that time but recommended continuing labor for another hour to see if she would progress. Shortly after this, however, uterine hyperstimulation with fetal tachycardia began and a C/S was decided upon.
The infant was delivered about 50 minutes after this decision was made. The infant suffered hypoxic ischemic brain injury and was diagnosed with spastic quadriplegic cerebral palsy. He is wheelchair-bound, requires a G-tube for feeding, has normal cognitive abilities, and can communicate with sophisticated technology.
In the lawsuit that followed this delivery, the claim was that the nursing staff failed to turn off the oxytocin and failed to have an operating room ready in a timely manner, as the delivery was about 50 minutes after the decision to perform a C/S was made.
Department editor DAWN COLLINS, JD, is an attorney specializing in medical malpractice in Long Beach, CA. She welcomes feedback on this column via e-mail to DawnCF@aol.com
.
Hormone therapy safety: Study finds potential benefits for senior women
April 24th 2024A recent large-scale study challenged age-related concerns, suggesting hormone therapy may offer safety and even benefits for menopausal women aged over 65 years, aligning with The Menopause Society's 2022 Position Statement.
Read More
Hyperoxygenation use not linked to neonatal outcomes
April 23rd 2024Recent research evaluated the impact of maternal hyperoxygenation on neonatal Apgar scores, revealing no significant enhancement in outcomes among women with pathologic fetal heart rate tracing and suggesting limited efficacy of hyperoxygenation therapy in this context.
Read More
Study finds antihypertensive treatment reduces uterine fibroids risk
April 23rd 2024A recent study revealed that patients with untreated or new-onset hypertension face elevated chances of uterine fibroid diagnosis, underscoring the potential of antihypertensive therapy in mitigating this risk among midlife individuals.
Read More